Nicorandil

尼可地尔

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameNicorandil
Drug Alias NameAdancorSigmart喜格迈DancorIkorel +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel agonistsVoltage-gated potassium channel agonists
TargetsVoltage-gated potassium channelPotassium channel
Therapy Area/IndicationsCognitive DysfunctionNo-Reflow PhenomenonDiabetes Mellitus, Type 2 +[9] 
Global Approved IndicationsCoronary DiseaseAngina PectorisHeart Failure
Approved Indications in ChinaAngina Pectoris
Original Approved Country/TerritoryJapan
Original Approved Date1983/09/21
Country/TerritoryUnited StatesEgyptMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChugai Pharma China Co LtdTanta UniversityNational Institute On Aging (NIA) +[5] 
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionNo-Reflow PhenomenonDiabetes Mellitus, Type 2 +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeC01DX16
Related LinksWikipediaDrugBankKEGG